Intel Sells 51% of Altera; Switches to Equity Accounting

Intel's sale of a 51% stake in Altera triggers deconsolidation and a move to equity-method accounting for the remaining interest. Under the new treatment Intel will no longer include Altera's standalone revenue and expenses on a consolidated basis; instead it will reflect its proportional share of Altera's results through equity income (as described by the company in its disclosures). That change will remove Altera's roughly $816 million of H1 2025 revenue (at an indicated ~55% gross margin) from Intel's consolidated top line and replace those line items with a single equity income line item representing Intel's share of Altera's net earnings. The company has quantified a related reduction in non-GAAP operating expense following the divestiture: non‑GAAP OPEX is reduced to $16.8 billion for 2025 and to $16.0 billion for 2026 per the company's disclosures. Investors should expect a one-time shift in reported revenue and expense presentation; comparisons of year-over-year consolidated revenue and segment results will need to adjust for the change to interpret organic performance.

Intel's decision to sell a majority interest in Altera aligns with its stated multi-year priorities to sharpen product focus, tighten financial discipline, and reallocate resources toward priority areas such as client/data‑center x86 and AI compute, process‑technology advancement, and foundry expansion. Removing Altera from consolidation reduces near-term non‑GAAP operating expense and may free management capacity and capital to execute on core engineering and foundry goals noted in company materials. The transaction also carries the specific risks the company has disclosed for divestitures and operations: potential regulatory approvals tied to the sale, continued exposure to macro and geopolitical supply‑chain pressures, and execution risks tied to product development and manufacturing expansion. Intel's filings highlight that divestitures can materially change consolidated results and referenced Altera's historical revenue and margins as part of that assessment.

Key items for investors to monitor following the sale: - How Intel reports its equity income from Altera in upcoming periodic filings and the timing of the first equity‑method recognition. - Any transitional arrangements affecting customer contracts, supply agreements, or shared services that could affect near‑term results. - Management commentary on how proceeds, cost savings, or reduced operating expense from the divestiture will be redeployed against Intel's stated priorities (R&D, CapEx, foundry build‑out). Given the company's own disclosure of Altera's contribution (H1 2025 revenue and margin) and the stated non‑GAAP OPEX reductions, investors should adjust comparable models and watch for management detail in the next earnings update and regulatory filings.